1,8-naphthyridine compounds for the treatment of cancer
US8124773B2 · kind B2 · utility
10Cited by
19References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2007 |
| Grant date | Feb 28, 2012 |
| Priority date | — |
| Expiry date | Jul 17, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise SNS-595 and N-desmethyl-SNS-595. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment using the compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.